Skip to content
10-Q/A

Quarterly Report

ARYA SCIENCES ACQUISITION CORP IV

0001140361-24-026933

← back to feed
Filed
May 21, 2024 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$511.69K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$211.03K
Cash And Equivalents Q1 2024 · Mar 31, 2024 $87.51K
Cash And Equivalents Q1 2024 · Dec 31, 2023 $20.19K
Cash And Equivalents Q1 2024 · Mar 31, 2023 $60.02K
Cash And Equivalents Q1 2024 · Dec 31, 2022 $91.05K
Stockholders Equity Q1 2024 · Mar 31, 2024 −$14.52M
Stockholders Equity Q1 2024 · Dec 31, 2023 −$14.79M
Stockholders Equity Q1 2024 · Mar 31, 2023 −$10.03M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$8.64M
Current Liabilities Q1 2024 · Mar 31, 2024 $12.15M
Current Liabilities Q1 2024 · Dec 31, 2023 $12.35M
Total Liabilities Q1 2024 · Mar 31, 2024 $14.76M
Total Liabilities Q1 2024 · Dec 31, 2023 $14.97M
Current Assets Q1 2024 · Mar 31, 2024 $140.9K
Current Assets Q1 2024 · Dec 31, 2023 $76.74K
Total Assets Q1 2024 · Mar 31, 2024 $37.26M
Total Assets Q1 2024 · Dec 31, 2023 $40.65M
Sga Expense Q1 2024 · Mar 31, 2024 $611.74K
Sga Expense Q1 2024 · Mar 31, 2023 $968.6K
Net Income Q1 2024 · Mar 31, 2024 −$245.85K
Net Income Q1 2024 · Mar 31, 2023 $160.25K
Operating Income Q1 2024 · Mar 31, 2024 −$611.74K
Operating Income Q1 2024 · Mar 31, 2023 −$968.6K